Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
Stephen A. Smith Is the Face of ESPN. How Much Is That Worth?
The opinionated ‘First Take’ co-host has been offered $18 million a year to stay, a sign of his growing importance to the network.
Higher Prices on Tampons, Pads Prompt Hard Choices for Americans
With few low-price alternatives available in the feminine-product aisle, sales of period products are falling as many women and girls find their budgets can’t cover […]
Lamb Weston Replaces CEO, Cuts Outlook
Lamb Weston Holdings said it was replacing its chief executive and slashing guidance again as demand for frozen potato products sputters, sending shares sharply lower.